Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2014

01.03.2014 | General Gynecology

Computed tomography adnexal mass score to estimate risk for ovarian cancer

verfasst von: Joseph T. Santoso, Aimee Robinson, Sri Suganda, Sirinya Praservit, Jim Y. Wan, Fred Ueland

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

We wish to develop a CT scan-based scoring system which estimates the probability of adnexal mass malignancy.

Methods

Patients (324) undergoing adnexal mass surgery were recruited into the study from June 1, 2002, to January 1, 2009. All study patients had a preoperative CT scan and serum CA-125 test. CT scan abnormalities included any solid tumor components, ascites, and pelvic or abdominal lymphadenopathy and omental caking.

Results

There were 225 (70 %) benign and 99 (30 %) malignant ovarian masses. Using logistic regression with the area under the curve of the receiver operating curve of 82 %, the cancer probability was determined by the equation.
$$ \frac{{{\text{e}}^{{ - 3. 6 3 7 2 { } + \, 0.0 30 6 { }* \, \left( {\text{A}} \right) \, + \, 0.00 1 { }* \, \left( {\text{B}} \right) \, + \, 0.{ 876 }* \, \left( {\text{C}} \right) + 1. 5 5 1 { }* \, \left( {\text{D}} \right) \, + { 1}. 7 3 7 7 { }* \, \left( {\text{E}} \right) \, + { 2}. 7 6 { }* \, \left( {\text{F}} \right)}} }}{{ 1+ {\text{e}}^{{ - 3. 6 3 7 2 { } + \, 0.0 30 6 { }* \, \left( {\text{A}} \right) \, + \, 0.00 1 { }* \, \left( {\text{B}} \right) \, + \, 0. 8 7 6 { }* \, \left( {\text{C}} \right) \, + { 1}. 5 5 1 { }* \, \left( {\text{D}} \right) \, + { 1}. 7 3 7 7 { }* \, \left( {\text{E}} \right) \, + { 2}. 7 6 { }* \, \left( {\text{F}} \right)}} }} $$
where A = age, B = CA-125, C = solid adnexal mass is 1 and cystic is 0, D = ascites is 1, E = omental caking is 1 and absence is 0, F = node size ≥1 cm is 1 and <1 cm is 0 value. The natural logarithm e is a constant [2.718281828]. For example, for a woman of age 60, CA-125 = 50 U/mL, with solid adnexal mass, ascites, omental caking, and lymphadenopathy, the probability is 0.994. Hence, this woman has a 99.4 % probability of having cancer.

Conclusion

The computed tomography adnexal mass score combines CT scan findings, CA-125, and patient age into an equation to predict the malignant probability of an adnexal mass.
Literatur
1.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK [eds]. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011 Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK [eds]. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2008/​, based on November 2010 SEER data submission, posted to the SEER web site, 2011
2.
Zurück zum Zitat Myers ER, Bastian LA, Havrilesky LJ, et al. (2006) Management of adnexal mass. Evidence report/technology assessment no. 130. AHRQ publication 06-E004.2 Myers ER, Bastian LA, Havrilesky LJ, et al. (2006) Management of adnexal mass. Evidence report/technology assessment no. 130. AHRQ publication 06-E004.2
3.
Zurück zum Zitat Ferrazzi E, Zanetta G, Dordoni D, Berlanda N, Mezzopane R, Lissoni AA, Lissoni G (1997) Transvaginal ultrasonographic characterization of ovarian masses. Ultrasound Obstet Gynecol 10(3):192–197PubMedCrossRef Ferrazzi E, Zanetta G, Dordoni D, Berlanda N, Mezzopane R, Lissoni AA, Lissoni G (1997) Transvaginal ultrasonographic characterization of ovarian masses. Ultrasound Obstet Gynecol 10(3):192–197PubMedCrossRef
4.
Zurück zum Zitat Merz E, Weber G, Bahlmann F, Kiesslich R (1998) A new sonomorphologic scoring system [Mainz Score] for the assessment of ovarian tumors using transvaginal ultrasonography. Part I: a comparison between the scoring-system and the assessment by an experienced sonographer. Ultraschall Med 19(3):99–107PubMedCrossRef Merz E, Weber G, Bahlmann F, Kiesslich R (1998) A new sonomorphologic scoring system [Mainz Score] for the assessment of ovarian tumors using transvaginal ultrasonography. Part I: a comparison between the scoring-system and the assessment by an experienced sonographer. Ultraschall Med 19(3):99–107PubMedCrossRef
5.
Zurück zum Zitat Weber G, Merz E, Bahlmann F, Leber AM (1999) A new sonomorphologic scoring-system [Mainz score] for the assessment of ovarian tumors using transvaginal ultrasonography. Part II: a comparison between the scoring-system and the assessment by an experienced sonographer in postmenopausal women. Ultraschall Med 20(1):2–8PubMedCrossRef Weber G, Merz E, Bahlmann F, Leber AM (1999) A new sonomorphologic scoring-system [Mainz score] for the assessment of ovarian tumors using transvaginal ultrasonography. Part II: a comparison between the scoring-system and the assessment by an experienced sonographer in postmenopausal women. Ultraschall Med 20(1):2–8PubMedCrossRef
6.
Zurück zum Zitat DePriest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, Pavlik EJ, Kryscio RJ, Jr Van Nagell JR (1993) A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol 51(1):7–11PubMedCrossRef DePriest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, Pavlik EJ, Kryscio RJ, Jr Van Nagell JR (1993) A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol 51(1):7–11PubMedCrossRef
7.
Zurück zum Zitat Ueland FR, DePriest PD, Pavlik EJ, Kryscio RJ, Jr Van Nagell JR (2003) Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol 91(1):46–50PubMedCrossRef Ueland FR, DePriest PD, Pavlik EJ, Kryscio RJ, Jr Van Nagell JR (2003) Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol 91(1):46–50PubMedCrossRef
8.
Zurück zum Zitat Sawicki W, Spiewankiewicz B, Cendrowski K, Stelmachow J (2001) Preoperative discrimination between malignant and benign adnexal masses with transvaginal ultrasonography and color blood flow imaging. Eur J Gynaecol Oncol 22(2):137–142PubMed Sawicki W, Spiewankiewicz B, Cendrowski K, Stelmachow J (2001) Preoperative discrimination between malignant and benign adnexal masses with transvaginal ultrasonography and color blood flow imaging. Eur J Gynaecol Oncol 22(2):137–142PubMed
9.
Zurück zum Zitat Twickler DM, Forte TB, Santos-Ramos R, McIntire D, Harris P, Scott D (1999) The ovarian tumor index predicts risk for malignancy. Cancer 86(11):2280–2290PubMedCrossRef Twickler DM, Forte TB, Santos-Ramos R, McIntire D, Harris P, Scott D (1999) The ovarian tumor index predicts risk for malignancy. Cancer 86(11):2280–2290PubMedCrossRef
10.
Zurück zum Zitat Varras M (2004) Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer. Clin Exp Obstet Gynecol 31(2):85–98PubMed Varras M (2004) Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer. Clin Exp Obstet Gynecol 31(2):85–98PubMed
11.
Zurück zum Zitat ACOG practice bulletin no. 83, 2007. Management of adnexal mass ACOG practice bulletin no. 83, 2007. Management of adnexal mass
12.
Zurück zum Zitat Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S, Van Holsbeke C, Savelli L, Fruscio R, Lissoni AA, Testa AC, Veldman J, Vergote I, Van Huffel S, Bourne T, Valentin L (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery. BMJ 341:c6839PubMedCrossRefPubMedCentral Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S, Van Holsbeke C, Savelli L, Fruscio R, Lissoni AA, Testa AC, Veldman J, Vergote I, Van Huffel S, Bourne T, Valentin L (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery. BMJ 341:c6839PubMedCrossRefPubMedCentral
13.
Zurück zum Zitat Buy JN, Ghossain MA, Sciot C, Bazot M, Guinet C, Prévot S, Hugol D, Laromiguiere M, Truc JB, Poitout P (1991) Epithelial tumors of the ovary: CT findings and correlation with US (1991). Radiology 178(3):811–818PubMed Buy JN, Ghossain MA, Sciot C, Bazot M, Guinet C, Prévot S, Hugol D, Laromiguiere M, Truc JB, Poitout P (1991) Epithelial tumors of the ovary: CT findings and correlation with US (1991). Radiology 178(3):811–818PubMed
14.
Zurück zum Zitat Tempany CM, Zou KH, Ilverman SG, Brown DL, Kurtz AB, McNeil BJ (2000) Staging of advanced ovarian cancer: comparison of imaging modalities–report from the Radiological Diagnostic Oncology Group. Radiology 215(3):761–767PubMedCrossRef Tempany CM, Zou KH, Ilverman SG, Brown DL, Kurtz AB, McNeil BJ (2000) Staging of advanced ovarian cancer: comparison of imaging modalities–report from the Radiological Diagnostic Oncology Group. Radiology 215(3):761–767PubMedCrossRef
15.
Zurück zum Zitat Brooks SE (1994) Preoperative evaluation of patients with suspected ovarian cancer. Gynecol Oncol 55(3 Pt 2):S80–S90PubMedCrossRef Brooks SE (1994) Preoperative evaluation of patients with suspected ovarian cancer. Gynecol Oncol 55(3 Pt 2):S80–S90PubMedCrossRef
16.
Zurück zum Zitat Kawamoto S, Urban BA, Fishman EK (1999) CT scan of epithelial ovarian tumors. Radiographics. 19 Spec No:S85–102; quiz S263–264 Kawamoto S, Urban BA, Fishman EK (1999) CT scan of epithelial ovarian tumors. Radiographics. 19 Spec No:S85–102; quiz S263–264
17.
Zurück zum Zitat Padilla LA, Radosevich DM, Milad MP (2005) Limitation of pelvic exam for evaluation of the female pelvic organs. Int J Gynaecol Obstet 88:84–88PubMedCrossRef Padilla LA, Radosevich DM, Milad MP (2005) Limitation of pelvic exam for evaluation of the female pelvic organs. Int J Gynaecol Obstet 88:84–88PubMedCrossRef
18.
Zurück zum Zitat Timmerman D, Van Calster B, Testa AC, Guerriero S, Fischerova D, Lissoni AA, Van Holsbeke C, Fruscio R, Czekierdowski A, Jurkovic D, Savelli L, Vergote I, Bourne T, Van Huffel S, Valentin L (2010) Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol 36(2):226–234PubMedCrossRef Timmerman D, Van Calster B, Testa AC, Guerriero S, Fischerova D, Lissoni AA, Van Holsbeke C, Fruscio R, Czekierdowski A, Jurkovic D, Savelli L, Vergote I, Bourne T, Van Huffel S, Valentin L (2010) Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol 36(2):226–234PubMedCrossRef
19.
Zurück zum Zitat Ware Miller R, Smith A, Desimone CP, Seamon LG, Goodrich S, Podzielinski I, Sokoll L, Jr Van Nagell JR, Ueland FR (2011) Performance of the American College of Obstetrics and Gynecologists’ ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol 117(6):1268–1306CrossRef Ware Miller R, Smith A, Desimone CP, Seamon LG, Goodrich S, Podzielinski I, Sokoll L, Jr Van Nagell JR, Ueland FR (2011) Performance of the American College of Obstetrics and Gynecologists’ ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol 117(6):1268–1306CrossRef
20.
Zurück zum Zitat Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, Sokoll L, Smith A, Jr van Nagell JR (2011) Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet Gynecol 117(6):1289–1297PubMedCrossRef Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, Sokoll L, Smith A, Jr van Nagell JR (2011) Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet Gynecol 117(6):1289–1297PubMedCrossRef
21.
Zurück zum Zitat Tsili AC, Dalkalitsis N, Paraskevaidis E, Tsampoulas K (2010) Multi-detector CT features of benign adnexal lesions. Acad Radiol 17(1):31–38PubMedCrossRef Tsili AC, Dalkalitsis N, Paraskevaidis E, Tsampoulas K (2010) Multi-detector CT features of benign adnexal lesions. Acad Radiol 17(1):31–38PubMedCrossRef
22.
Zurück zum Zitat Tsili AC, Tsampoulas C, Charisiadi A, Kalef-Ezra J, Dousias V, Paraskevaidis E, Efremidis SC (2008) Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol 110(1):22–31PubMedCrossRef Tsili AC, Tsampoulas C, Charisiadi A, Kalef-Ezra J, Dousias V, Paraskevaidis E, Efremidis SC (2008) Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol 110(1):22–31PubMedCrossRef
23.
Zurück zum Zitat Kubik-Huch RA, Dorffler W, von Schulthess GK, Marincek B, Kochli OR, Seifert B, Haller U, Steinert HC (2000) Value of [18F]-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 10(5):761–767PubMedCrossRef Kubik-Huch RA, Dorffler W, von Schulthess GK, Marincek B, Kochli OR, Seifert B, Haller U, Steinert HC (2000) Value of [18F]-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 10(5):761–767PubMedCrossRef
24.
Zurück zum Zitat Kormano M, Alanen A, Gronroos M (1984) Predicting malignancy of suspected ovarian tumours by CT. Eur J Radiol 4(1):61–64PubMed Kormano M, Alanen A, Gronroos M (1984) Predicting malignancy of suspected ovarian tumours by CT. Eur J Radiol 4(1):61–64PubMed
25.
Zurück zum Zitat Rohde U, Steinbrich W (1983) Differential diagnosis of ovarian benign and malignant tumors by CT. J Belge Radiol 66(1):9–14PubMed Rohde U, Steinbrich W (1983) Differential diagnosis of ovarian benign and malignant tumors by CT. J Belge Radiol 66(1):9–14PubMed
26.
Zurück zum Zitat McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik E, Goodrich S, Kryscio RJ, van Nagell JR (2000) Predicting risk of malignancy in adnexal masses. Obstet Gynecol 115(4):687–694CrossRef McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik E, Goodrich S, Kryscio RJ, van Nagell JR (2000) Predicting risk of malignancy in adnexal masses. Obstet Gynecol 115(4):687–694CrossRef
27.
Zurück zum Zitat Im SS, Gordon AN, Buttin BM, Leath CA 3rd, Gostout BS, Shah C, Hatch KD, Wang J, Berman ML (2005) Validation of referral guidelines for women with pelvic masses. Obstet Gynecol 105(1):35–41PubMedCrossRef Im SS, Gordon AN, Buttin BM, Leath CA 3rd, Gostout BS, Shah C, Hatch KD, Wang J, Berman ML (2005) Validation of referral guidelines for women with pelvic masses. Obstet Gynecol 105(1):35–41PubMedCrossRef
Metadaten
Titel
Computed tomography adnexal mass score to estimate risk for ovarian cancer
verfasst von
Joseph T. Santoso
Aimee Robinson
Sri Suganda
Sirinya Praservit
Jim Y. Wan
Fred Ueland
Publikationsdatum
01.03.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2014
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-013-3013-7

Weitere Artikel der Ausgabe 3/2014

Archives of Gynecology and Obstetrics 3/2014 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.